HIV-1 virus - Globe Thesis

Keyword [HIV-1 virus] Result: 1 - 20 \| Page: 1 of 2
1.	Preclinical Phase Study Of HIV-1 Virus-Like Particles Vaccine
2.	Synthesis Of Novel HIV-1 Virus Assembly Inhibitors
3.	Isolation And Sequence Analysis Of HIV-1 Strains Circulating In Some Regions Of China
4.	Bst-2 Inhibition Of Influenza Virus And Hiv-1 Virus-like Particle Release
5.	Design, Synthesis And Biological Evaluation Of Novel Pyrrolothiadiazines Derivatives As HIV-1 NNRTIs
6.	Molecular Dynamics Simulation Studies On The Mechanism Of Neutralizing HIV-1 Virus By A Series Of Antibodies Targeting Gp120
7.	Inhibiting The Infection Of Pseudotyped HIV-1 Virus By Gene Targeted Editing Of CCR5 Based On TALEN
8.	Study On The Mechanism Of AID Suppressing HIV-1 Virus Replication
9.	Study On The Mechanism Of Metalloproteinase TRABD2A Suppressing HIV-1 Virus Replication
10.	Study On The Effect Of HIV-1 Latency-reversing Drug Combinations Reversing Latency HIV-1 Virus In CD4~+T Cell Memory Subsets
11.	Study On The Impact Of Viral Mutations Generated During Early Infection Stage On HIV-1 Fitness
12.	Improved Human Immunodeficiency Virus(HIV) Outgrowth Assay And Murine Models By A Dcas9 Activation System
13.	Isolation and characterization of RNA aptamers targeted to the aspartyl protease of the human immunodeficiency virus type 1 (HIV-1)
14.	Induction of strong cellular immune responses in the gut mucosa against HIV-1 using a combination vaccine of recombinant Clostridium perfringens and HIV-1 virus like particles
15.	Stabilization of human immunodeficiency virus type 1 envelope glycoprotein conformations
16.	Host and viral factors contribute to modulation of human immunodeficiency virus replication in monocytes/macrophages
17.	Persistence of HIV-1 despite highly active antiretroviral therapy (HAART) and immune responses: Evidence for a novel viral reservoir in patients on HAART and characterization of HIV-1 virus and immune responses in elite suppressors
18.	Fusion glycoproteins of HIV-1 and the Ebola Virus: Structure, function, and inhibition with antibodies
19.	Optimizing vaccine strategies to induce HIV-1 virus-specific cytotoxic T-lymphocyte activity
20.	Visualization of HIV-Associated Neurocognitive Disorders
<<First <Prev Next> Last>> Jump to